Axogen Inc vs Danaos Corporation — how do they compare? Axogen Inc trades at $39.4 (market cap $2.06B), while Danaos Corporation trades at $129.89 (market cap $2.36B). The key difference: Axogen Inc and Danaos Corporation are close in size by market cap, and Danaos Corporation pays a 2.78% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | DAC | |
|---|---|---|
Market Cap | $2.06B | $2.36B |
Sector | Technology | Technology |
52-Week High | $46.19 | $134.63 |
52-Week Low | $11.28 | $84.05 |
Enterprise Value | $1.98B | $2.36B |
Dividend Yield | — | 2.78% |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
Danaos Corporation (DAC) trades at $129.35, up 0.75% today, with a bullish technical signal from moving averages. The stock shows strong fundamentals with a P/E of 4.57, P/B of 0.6, and net income margin of 49.85% (2026 trend). Recent Q1 2026 earnings beat expectations, and the company maintains a consistent dividend policy. Analyst sentiment is mixed with a 40% buy rating. The stock is near resistance at $130, with RSI_6 indicating potential overbought conditions.
The outlook for DAC remains positive due to attractive valuation, high profitability, and a robust containership backlog. Key risks include exposure to shipping rate volatility and capital allocation decisions. Upside potential is supported by earnings momentum and dividend yield, but investors should monitor industry cyclicality and execution on fleet expansion.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →Danaos is a leading international owner of containerships, providing seaborne transportation services globally. It charters its fleet of vessels to major shipping lines across Asia, Europe, and the Americas.
Read more on DAC →